2002
DOI: 10.1074/jbc.m204731200
|View full text |Cite
|
Sign up to set email alerts
|

Basal Transcription of the Mouse Sarco(endo)plasmic Reticulum Ca2+-ATPase Type 3 Gene in Endothelial Cells Is Controlled by Ets-1 and Sp1

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
22
2

Year Published

2004
2004
2019
2019

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 23 publications
(24 citation statements)
references
References 52 publications
0
22
2
Order By: Relevance
“…38 -49 The TATA-less human and mouse SERCA3 promoters contain several Sp1-binding sequences, which have been shown, along with ETS-binding sites, to direct basal SERCA3 expression in mouse vascular endothelial cells. 22,50 The inhibition by mithramycin-A of the constitutive residual expression of SERCA3 in COLO-205 cells, which is quantitatively similar to that observed in well-differentiated colon carcinoma tissue, suggests that Sp1-like factor-dependent transcription drives SERCA3 expression observed also in well differentiated tumors. Importantly, short chain fatty acid (ie, butyrate or valerate)-induced expression of SERCA3 in cells that initially express undetectable amounts of SERCA3 protein was also inhibited in a dose-dependent manner by mithramycin-A.…”
Section: Discussionmentioning
confidence: 53%
See 1 more Smart Citation
“…38 -49 The TATA-less human and mouse SERCA3 promoters contain several Sp1-binding sequences, which have been shown, along with ETS-binding sites, to direct basal SERCA3 expression in mouse vascular endothelial cells. 22,50 The inhibition by mithramycin-A of the constitutive residual expression of SERCA3 in COLO-205 cells, which is quantitatively similar to that observed in well-differentiated colon carcinoma tissue, suggests that Sp1-like factor-dependent transcription drives SERCA3 expression observed also in well differentiated tumors. Importantly, short chain fatty acid (ie, butyrate or valerate)-induced expression of SERCA3 in cells that initially express undetectable amounts of SERCA3 protein was also inhibited in a dose-dependent manner by mithramycin-A.…”
Section: Discussionmentioning
confidence: 53%
“…[25][26][27] Because Sp1-like factors are involved in the expression of SERCA3 in normal vascular endothelial cells, 22 the effect of mithramycin-A on short chain fattyacid-induced SERCA3 expression in colon and gastric cancer cell lines was studied by Western blotting. As shown in Figure 3A, the induction of SERCA3 expression in the DLD-1 colon cancer cell line by sodium valerate could be inhibited by mithramycin-A in a dose-dependent manner in the submicromolar concentration range.…”
Section: Inhibition Of Serca3 Expression By Mithramycin-amentioning
confidence: 99%
“…However, the SERCA3f protein should be of importance based on the study of h3f mRNA distribution, which demonstrates its expression in almost all human cell and tissue types. Hence, in contrast with previous suggestions, it is more and more evident that human SERCA3 gene products are not only expressed in a restricted number of adult tissues (33)(34)(35)(36)(37).…”
Section: Discussioncontrasting
confidence: 45%
“…The SERCA isoforms differ mainly by their affinity for Ca 2+ (2b > 2a = 1 >> 3) and their Ca 2+ transport turnover rates, SERCA2b having the lowest transport capacity of all SERCAs [350] . Both SERCA2a and SERCA3 have been found in isolated and in situ ECs [106,[351][352][353][354][355][356] , albeit SERCA3 transcript levels decrease during EC proliferation in culture and in hypertension [106,112] . SERCA3 expression is regulated by Ca 2+ itself in a calcineurin/NFAT-dependent manner [357] and its genetic deletion leads to a decrease in agonist-induced elevation in [Ca 2+ ]i and NO synthesis [358] .…”
Section: +mentioning
confidence: 99%